VELSIPITY Pfizer Australia Pty Ltd
Product name
VELSIPITY
Sponsor
Accepted date
Mar-2023
Active ingredients
etrasimod arginine
Proposed indication
For the treatment of patients with active ulcerative colitis (UC).
Application type
A (new medicine)
Publication date
Mar-23